Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis

Ticker
MDGL

Price
487.32
Stock movement up
+22.61 (4.87%)
Company name
Madrigal Pharmaceuticals Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
11.07B
Ent value
11.53B
Price/Sales
11.55
Price/Book
18.36
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
34.47
PEG
-
EPS growth
-0.37%
1 year return (CAGR)
38.56%
3 year return (CAGR)
23.51%
5 year return (CAGR)
31.23%
10 year return (CAGR)
53.22%
Last updated: 2026-03-13

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

MDGL does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales11.55
Price to Book18.36
EV to Sales12.03

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count22.71M
EPS (TTM)-12.85
FCF per share (TTM)-8.50

Income statement

Loading...
Income statement data
Revenue (TTM)958.40M
Gross profit (TTM)902.25M
Operating income (TTM)-300.10M
Net income (TTM)-288.28M
EPS (TTM)-12.85
EPS (1y forward)14.14

Margins

Loading...
Margins data
Gross margin (TTM)94.14%
Operating margin (TTM)-31.31%
Profit margin (TTM)-30.08%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash198.69M
Net receivables134.48M
Total current assets1.25B
Goodwill0.00
Intangible assets7.38M
Property, plant and equipment0.00
Total assets1.26B
Accounts payable48.88M
Short/Current long term debt354.36M
Total current liabilities310.29M
Total liabilities656.90M
Shareholder's equity602.69M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-189.55M
Capital expenditures (TTM)1.25M
Free cash flow (TTM)-190.80M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-47.83%
Return on Assets-22.89%
Return on Invested Capital-47.75%
Cash Return on Invested Capital-31.60%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open462.37
Daily high495.00
Daily low462.04
Daily Volume403K
All-time high602.83
1y analyst estimate667.57
Beta-0.96
EPS (TTM)-12.85
Dividend per share0.00
Ex-div date-
Next earnings date19 Feb 2026

Downside potential

Loading...
Downside potential data
MDGLS&P500
Current price drop from All-time high-19.16%-1.82%
Highest price drop-98.40%-56.47%
Date of highest drop11 Feb 20169 Mar 2009
Avg drop from high-59.17%-10.84%
Avg time to new high165 days12 days
Max time to new high3162 days1805 days
COMPANY DETAILS
MDGL (Madrigal Pharmaceuticals Inc) company logo
Marketcap
11.07B
Marketcap category
Large-cap
Description
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
Employees
915
Investor relations
-
SEC filings
CEO
Paul A. Friedman
Country
USA
City
West Conshohocken
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...